posted on 2008-12-08, 16:21authored byGabrielle S. Sellick, Lynn R. Goldin, Ruth W. Wild, Susan L. Slager, Laura Ressenti, Sara S. Strom, Martin J. S. Dyer, Francesca R. Mauro, Gerald E. Marti, Stephen Fuller, Matthew Lyttelton, Thomas J. Kipps, Michael J. Keating, Timothy G. Call, Daniel Catovsky, Neil Caporaso, Richard S. Houlston
Chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders display familial aggregation. To identify a susceptibility gene for CLL we assembled families from the major European (ICLLC) and American (GEC) consortia to conduct a genome-wide linkage analysis of 101 new CLL pedigrees using a high-density single nucleotide polymorphism (SNP) array and
combined the results with data from our previously reported analysis of 105 families. Here we report on the combined analysis of the 206 families. Multipoint linkage analyses were undertaken using both non-parametric (model-free) and parametric (model-based) methods. After the removal
of high linkage disequilibrium SNPs we obtained a maximum NPL of 3.02 (P= 1.3 x 10-3) on chromosome 2q21.2. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a common recessive model of disease susceptibility (HLOD = 3.11; P= 7.7 x 10-5) which was significant at the genome-wide level. In addition, 2 other chromosomal
positions 6p22.1 (corresponding to the major histocompatibility locus) and 18q21.1 displayed HLOD scores >2.1 (P < 0.002). None of the regions coincided with areas of common chromosomal abnormalities frequently observed in CLL. These findings provide direct evidence for Mendelian
predisposition to CLL and evidence for the location of disease loci.